Establishment of T-helper type 2 clone-induced eosinophilia in mouse conjunctiva

Experimental Eye Research

Volumn 69, Issue 1, 1999, Pages 69-74

  Hamada, Muneo ^a   Sawa, Kenjiro ^a   Nakata, Katsuhiko ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Conjunctivitis; D10.G4.1. eosinophils; Interleukin 4; Interleukin 5; Monoclonal antibody; Mouse; Neutrophils; T helper type 2

Indexed keywords

ANTIALLERGIC AGENT; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5 ANTIBODY; MONOCLONAL ANTIBODY; OVOTRANSFERRIN; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONJUNCTIVA; CONJUNCTIVITIS; CONTROLLED STUDY; DEGRANULATION; EOSINOPHIL; EOSINOPHILIA; FEMALE; HELPER CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; RAT; REACTION TIME; TH2 CELL; VERNAL CONJUNCTIVITIS;

EID: 0032765363     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1999.0677     Document Type: Article

References (31)

1. Abelson M. B., Butrus S. I., Weston J. H. Aspirin therapy in vernal conjunctivitis. Am. J. Ophthalmol. 95:1983a;502-505.
2. Abelson M. B., Madiwale N., Weston J. H. Conjunctival eosinophils in allergic ocular disease. Arch. Ophthalmol. 101:1983b;555-556.
3. Bohjanen P. R., Okajima M., Hodes R. J. Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T-cell gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc. Natl Acad. Sci. USA. 87:1990;5283-5287.
4. Bonini S., Bonini S., Lambiase A., Magrini L., Rumi C., Del Prete G., Schiavone M., Rotiroti G., Onorati P., Rutella S. Vernal keratoconjunctivitis: a model of 5q cytokine gene cluster disease. Int. Arch Allergy Immunol. 107:1995;95-98.
5. Clark R. B., Ballow M. Long-term T-cell lines from the tears of patients with vernal conjunctivitis. J. Clin. Lab. Immunol. 15:1984;91-94.
6. Foster P. S., Hogan S. P., Ramsay A. J., Matthaei K. I., Young I. G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model [see comments]. J. Exp. Med. 183:1996;195-201.
7. Fujishima H., Takeuchi T., Shinozaki N., Saito I., Tsubota K. Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin. Exp. Immunol. 102:1995;395-398.
8. Goldschmidt P., Luyckx J. Effects of lodoxamide (LOD), disodium cromoglycate (DSCG) and N-acetyl-aspartyl-glutamate sodium salt (NAAGA) on ocular active anaphylaxis. Allerg. Immunol. (Paris). 28:1996;124-126.
9. Gradehandt G., Kleber N., Mattner F., Milbradt S., Rude E. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide. Immunology. 78:1993;592-599.
10. Gulbenkian A. R., Egan R. W., Fernandez X., Jones H., Kreutner W., Kung T., Payvandi F., Sullivan L., Zurcher J. A., Watnick A. S. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am. Rev. Respir. Dis. 146:1992;263-266.
11. Iwamoto I., Tomoe S., Tomioka H., Takatsu K., Yoshida S. Role of CD4+ T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice. J. Leukoc. Biol. 52:1992;572-578.
12. Kaneko M., Hitoshi Y., Takatsu K., Matsumoto S. Role of interleukin-5 in local accumulation of eosinophils in mouse allergic peritonitis. Int. Arch Allergy Appl. Immunol. 96:1991;41-45.
13. Khatami M., Donnelly J. J., John T., Rockey J. H. Vernal conjunctivitis. Model studies in guinea pigs immunized topically with fluoresceinyl ovalbumin. Arch Ophthalmol. 102:1984;1683-1688.
14. Khosravi E., Elena P. P., Hariton C. Allergic conjunctivitis and uveitis models: reappraisal with some marketed drugs. Inflamm. Res. 44:1995;47-54.
15. Li Q., Luyo D., Hikita N., Whitcup S. M., Chan C. C. Compound 48/80-induced conjunctivitis in the mouse: kinetics, susceptibility, and mechanism. Int. Arch. Allergy Immunol. 109:1996;277-285.
16. Lopez A. F., Sanderson C. J., Gamble J. R., Campbell H. D., Young I. G., Vadas M. A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:1988;219-224.
17. Maggi E., Biswas P., Del Prete G., Parronchi P., Macchia D., Simonelli C., Emmi L., De Carli M., Tiri A., Ricci M. et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J. Immunol. 146:1991;1169-1174.
18. Merayo-Lloves J., Zhao T. Z., Dutt J. E., Foster C. S. A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium. J. Allergy Clin. Immunol. 97:1996;1129-1140.
19. Moser R., Groscurth P., Carballido J. M., Bruijnzeel P. L., Blaser K., Heusser C. H., Fehr J. Interleukin-4 induces tissue oesinophilia in mice: correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophils. J. Lab. Clin. Med. 122:1993;567-575.
20. Mould A. W., Matthaei K. I., Young I. G., Foster P. S. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1997;1064-1071.
21. Muller, K. M., Rocken, M., Carlberg, C. and Hauser, C. (1995). The induction and functions of murine T-helper cell subsets. J. Invest. Dermatol. 105, 8s-13s.
22. Nagai H., Yamaguchi S., Inagaki N., Tsuruoka N., Hitoshi Y., Takatsu K. Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sci. 53:1993;PI243-7.
23. Naora H., Young I. G. Comparison of the mechanisms regulating IL-5, IL-4, and three other lymphokine genes in the Th2 clone D10.G4.1. Exp. Hematol. 23:1995;597-602.
24. Rothenberg M. E., Petersen J., Stevens R. L., Silberstein D. S., McKenzie D. T., Austen K. F., Owen W. F., Jr. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J. Immunol. 143:1989;2311-2316.
25. Saiga T., Shimizu Y. Activated eosinophils in vernal keratoconjunctivitis. Nippon Rinsho. 51:1993;816-819.
26. Schleimer R. P., Sterbinsky S. A., Kaiser J., Bickel C. A., Klunk D. A., Tomioka K., Newman W., Luscinskas F. W., Gimbrone M. A., Jr., McIntyre B. W. et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J. Immunol. 148:1992;1086-1092.
27. Schmidt J., Hatzelmann A., Fleissner S., Heimann-Weitschat I., Lindstaedt R., Szelenyi I. Effect of phosphodiesterase inhibition on IL-4 and IL-5 production of the murine T(H)2-type t cell clone D10.G4.1. Immunopharmacology. 30:1995;191-198.
28. Vezzio N., Sarfati M., Yang L. P., Demeure C. E., Delespesse G. Human Th2-like cell clones induce IL-12 production by dendritic cells and may express several cytokine profiles. Int. Immunol. 8:1996;1963-1970.
29. Wang J. M., Rambaldi A., Biondi A., Chen Z. G., Sanderson C. J., Mantovani A. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19:1989;701-705.
30. Whitcup S. M., Chan C. C., Luyo D. A., Bo P., Li Q. Topical cyclosporine inhibits mast cell-mediated conjunctivitis. Invest. Ophthalmol. Vis. Sci. 37:1996;2686-2693.
31. Yamaya H., Basaki Y., Togawa M., Kojima M., Kiniwa M., Matsuura N. Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents. Life Sci. 56:1995;1647-1654.